收费全文 | 743286篇 |
免费 | 65601篇 |
国内免费 | 47007篇 |
耳鼻咽喉 | 7285篇 |
儿科学 | 8937篇 |
妇产科学 | 10563篇 |
基础医学 | 83628篇 |
口腔科学 | 13255篇 |
临床医学 | 96292篇 |
内科学 | 108037篇 |
皮肤病学 | 8437篇 |
神经病学 | 38080篇 |
特种医学 | 28441篇 |
外国民族医学 | 355篇 |
外科学 | 76975篇 |
综合类 | 125110篇 |
现状与发展 | 153篇 |
一般理论 | 83篇 |
预防医学 | 51222篇 |
眼科学 | 20204篇 |
药学 | 76984篇 |
682篇 | |
中国医学 | 42967篇 |
肿瘤学 | 58204篇 |
2024年 | 2278篇 |
2023年 | 10040篇 |
2022年 | 25869篇 |
2021年 | 33413篇 |
2020年 | 25156篇 |
2019年 | 21650篇 |
2018年 | 23324篇 |
2017年 | 21686篇 |
2016年 | 20497篇 |
2015年 | 31346篇 |
2014年 | 39587篇 |
2013年 | 37625篇 |
2012年 | 54996篇 |
2011年 | 61040篇 |
2010年 | 40592篇 |
2009年 | 32897篇 |
2008年 | 42249篇 |
2007年 | 41994篇 |
2006年 | 40943篇 |
2005年 | 38837篇 |
2004年 | 26386篇 |
2003年 | 24401篇 |
2002年 | 21026篇 |
2001年 | 18103篇 |
2000年 | 18036篇 |
1999年 | 18221篇 |
1998年 | 10739篇 |
1997年 | 10581篇 |
1996年 | 8321篇 |
1995年 | 7610篇 |
1994年 | 6501篇 |
1993年 | 4255篇 |
1992年 | 5880篇 |
1991年 | 5021篇 |
1990年 | 4325篇 |
1989年 | 3767篇 |
1988年 | 3213篇 |
1987年 | 2886篇 |
1986年 | 2372篇 |
1985年 | 1904篇 |
1984年 | 1143篇 |
1983年 | 842篇 |
1982年 | 533篇 |
1981年 | 502篇 |
1980年 | 425篇 |
1979年 | 538篇 |
1978年 | 254篇 |
1977年 | 235篇 |
1974年 | 249篇 |
1973年 | 217篇 |
2. Firstly, cell viability and biochemical indicators were determined and the cell morphology was observed to confirm the cell injury and develop a cell hepatotoxicity model. Then, with the help of cell metabolomics based on UPLC-MS, the Genkwa Flos group samples were completely separated from the blank group samples in the score plots and seven upregulated as well as two down-regulated putative biomarkers in the loading plot were identified and confirmed. Besides, two signal molecules and four enzymes involved in biosynthesis pathway of lysophosphatidylcholine and the sphingosine kinase/sphingosine-1-phosphate pathway were determined to investigate the relationship between Genkwa Flos hepatotoxicity and these two classic pathways. Finally, the metabolic pathways related to specific biomarkers and two classic metabolic pathways were analyzed to explain the possible mechanism of Genkwa Flos hepatotoxicity.
3. Based on the results, lipid peroxidation and oxidative stress, phospholipase A2/lysophosphatidylcholine pathway, the disturbance of sphingosine-1-phosphate metabolic profile centered on sphingosine kinase/sphingosine-1-phosphate pathway and fatty acid metabolism might be critical participators in the progression of liver injury induced by Genkwa Flos. 相似文献
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献- HIF were greater in number than AMFs, but AMFs increase in the presence of increasing HIF, suggesting an anatomic relationship.
- SLs were associated with greater numbers of both HIF and AMF/patient (pt.) versus no SL, 6.7 versus 2.7/pt. and 3.3 versus 2.0/pt., respectively. SL presence correlated more closely to HIF than to AMF presence within the entire 358-patient group.
- When HIF and AMF were classified as combined (concurrent HIF and AMF, with ≥1 of each both present in the same patient [HIF+AMF]) or continuous (AMF appearing to extend to and join an HIF [AMF>HIF]), HIF and AMF/pt. each differed numerically and patients with an SL had more combined HIF+AMF and continuous AMF>HIF than patients without an SL.
- In patients with both SL and combined HIF+AMF (a circumstance allowing the possibility of a relationship of all 3 structures), HIF become proportionally fewer compared with AMFs. In patients with an SL actually exhibiting continuous AMF>HIF, the HIF/AMF ratio decreased further.
Background
Comorbidities are commonly seen in patients with coronavirus disease 2019 (COVID-19), but the clinical implication is not yet well-delineated. We aim to characterize the prevalence and clinical implications of comorbidities in patients with COVID-19. 相似文献Context
Family caregivers constitute a critical component of the end-of-life care system with considerable cost to themselves. However, the joint association of terminally ill cancer patients' symptom distress and functional impairment with caregivers' subjective caregiving burden, quality of life (QOL), and depressive symptoms remains unknown.Objectives/Methods
We used multivariate hierarchical linear modeling to simultaneously evaluate associations between five distinct patterns of conjoint symptom distress and functional impairment (symptom-functional states) and subjective caregiving burden, QOL, and depressive symptoms in a convenience sample of 215 family caregiver–patient dyads. Data were collected every 2 to 4 weeks over patients' last 6 months.Results
Caregivers of patients in the worst symptom-functional states (States 3–5) reported worse subjective caregiving burden and depressive symptoms than those in the best two states, but the three outcomes did not differ between caregivers of patients in State 3 and States 4–5. Caregivers of patients in State 5 endured worse subjective caregiving burden and QOL than those in State 4. Caregivers of patients in State 4 suffered worse subjective caregiving burden and depressive symptoms but comparable QOL to those in State 2.Conclusion
Patients' five distinct, conjoint symptom-functional states were significantly and differentially associated with their caregivers' worse subjective caregiving burden, QOL, and depressive symptoms while caring for patients over their last 6 months. 相似文献- Key messages
This study compared the efficacy of inhaled prostacyclin or its analogues versus inhaled NO to treat PH after surgery. The two types of agent exhibited similar efficacy in managing MPAP, PVR, heart rate, and cardiac output was observed.
Inhaled prostacyclin may serve as an alternative treatment option for PH after cardiac or pulmonary surgery.